Bacteroides fragilis ubiquitin homologue drives intraspecies bacterial competition in the gut microbiome

Nat Microbiol. 2024 Jan;9(1):70-84. doi: 10.1038/s41564-023-01541-5. Epub 2023 Dec 11.

Abstract

Interbacterial antagonism and associated defensive strategies are both essential during bacterial competition. The human gut symbiont Bacteroides fragilis secretes a ubiquitin homologue (BfUbb) that is toxic to a subset of B. fragilis strains in vitro. In the present study, we demonstrate that BfUbb lyses certain B. fragilis strains by non-covalently binding and inactivating an essential peptidyl-prolyl isomerase (PPIase). BfUbb-sensitivity profiling of B. fragilis strains revealed a key tyrosine residue (Tyr119) in the PPIase and strains that encode a glutamic acid residue at Tyr119 are resistant to BfUbb. Crystal structural analysis and functional studies of BfUbb and the BfUbb-PPIase complex uncover a unique disulfide bond at the carboxy terminus of BfUbb to mediate the interaction with Tyr119 of the PPIase. In vitro coculture assays and mouse studies show that BfUbb confers a competitive advantage for encoding strains and this is further supported by human gut metagenome analyses. Our findings reveal a previously undescribed mechanism of bacterial intraspecies competition.

MeSH terms

  • Animals
  • Bacteria / metabolism
  • Bacterial Infections*
  • Bacteroides fragilis / genetics
  • Gastrointestinal Microbiome*
  • Humans
  • Mice
  • Peptidylprolyl Isomerase / metabolism
  • Ubiquitin / metabolism

Substances

  • Ubiquitin
  • Peptidylprolyl Isomerase